AKT1 and neoplasm: To determine whether the activation of the PERK/ eIF2α/ATF4/CHOP signaling pathway and inactivation of the AKT/mTOR signaling pathway were involved in CCT020312-induced tumor inhibition, we performed western blotting and IHC.